Status:
COMPLETED
Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion
Lead Sponsor:
Nordic Pharma SAS
Conditions:
Abortion; Attempted, Medical
Eligibility:
FEMALE
18+ years
Brief Summary
This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres. The aim of this study was to assess, in re...
Eligibility Criteria
Inclusion
- Adult women (18 years old or more), pregnant the day of the medical examination and asking for medical abortion.
- Patients agreeing to participate in the study after have been informed orally by the physician and given the information sheet.
- Informed patients accepting the computer processing of their medical data and their right of access and correction.
Exclusion
- Patients with more than 49 Days of Amenorrhea (DA) for private practice and 63 DA for hospital practice.
- Patients with contraindications to medical abortion.
- Patients with severe and progressive disease.
- Patients unable to complete a questionnaire.
- Patients refusing to participate in the study.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT02304835
Start Date
May 1 2013
End Date
November 1 2013
Last Update
December 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet Médical
Paris, France